These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2115504)

  • 21. Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.
    Linnenweber S; Lonnemann G
    Kidney Int Suppl; 2001 Feb; 78():S282-5. PubMed ID: 11169027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.
    Abe M; Hamano T; Wada A; Nakai S; Masakane I
    Am J Nephrol; 2017; 46(1):82-92. PubMed ID: 28675885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers.
    Pereira BJ; Snodgrass B; Barber G; Perella C; Chopra S; King AJ
    J Am Soc Nephrol; 1995 Oct; 6(4):1304-8. PubMed ID: 8589302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chemical germicides on the integrity of hemodialyzer membranes.
    Bland LA; Favero MS; Oxborrow GS; Aguero SM; Searcy BP; Danielson JW
    ASAIO Trans; 1988; 34(3):172-5. PubMed ID: 3058170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
    Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
    Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
    Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
    Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
    Schindler R; Ertl T; Beck W; Lepenies J; Boenisch O; Oppermann M; Kaspar E; Frei U
    Blood Purif; 2006; 24(2):203-11. PubMed ID: 16373999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
    Kadiri S; Kehinde Z; Arije A; Salako BL
    Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP; Kimmel PL; Phillips TM; Mishkin GJ; Lew SQ; Bosch JP
    Blood Purif; 2001; 19(4):370-9. PubMed ID: 11574733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.
    Abe M; Hamano T; Wada A; Nakai S; Masakane I;
    PLoS One; 2017; 12(9):e0184424. PubMed ID: 28910324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
    Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
    Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Automatic re-utilization of capillary dialysis].
    Szepietowski T; Uzar J
    Polim Med; 1989; 19(3-4):107-18. PubMed ID: 2641400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy.
    Djukanović LJ; Mimić-Oka JI; Potić JB
    Int J Artif Organs; 1989 Jan; 12(1):11-9. PubMed ID: 2538398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.